CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Methylprednisolone Sodium Succinate

Methylprednisolone· ingredient methylprednisoloneCorticosteroids, combinations for treatment of acne· METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1; METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mL; METHYLPREDNISOLONE SODIUM SUCCINATE 1 g/16mL; METHYLPREDNISOLONE SODIUM SUCCINATE 2 g/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$4.06
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other methylprednisolone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
methylprednisolone$0.12425−$3.94
Medrol$0.25840−$3.80
methylprednisolone$1.03−$3.03
DEPO-MEDROL$5.81+$1.75
Solu-Medrol$6.27+$2.21
Depo-Medrol$10.97+$6.91
Depo-Medrol$11.96+$7.90

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.